Dr Vijay Chauthaiwale

Last Updated on August 23, 2020

Dr Vijay Chauthaiwale, Ph.D. In-Charge, Foreign Affairs Dept Member, National Executive Bharatiya Janata Party

Dr Vijay is In-Charge, Department of Foreign Affairs, Bharatiya Janata Party (BJP), since November 2014. In this role, he is coordinating with Indian Diaspora worldwide through BJP’s global outreach platform, Overseas Friends of BJP (OFBJP). OFBJP has chapters in more than 40 countries and are comprised of well wishers of BJP.

Interaction with Indian Diaspora has been an essential component of overseas visits of Prime Minister Modi. Vijay is actively involved in coordinating community receptions to PM Modi across the globe. Additionally, he interacts with foreign embassies, diplomats and delegates of various countries to put forward party perspective on issues of mutual interests.

Dr Vijay participated in 2014 Lok Sabha election campaign (February-June 2014) by taking sabbatical from his professional work. He was stationed in the BJP Headquarters in New Delhi for campaign coordination.

Vijay M Chauthaiwale - Posts | Facebook

Dr Vijay is also member of following committees:

  • Board of Governors of Indian Institute of Management-Raipur 
  • Mission High Level Committee of Atal Innovation Mission (AIM), which is an umbrella body under NITI Aayog for all innovation related initiatives of Government of India.
  • Research Council of Central Drug Research Institute (CDRI-CSIR), lucknow.
  • Board of Health Technology Assessment in India (HTAIn), Ministry of Health, Govt of India.
  • Board of Governors of Indian Institute of Scientific Education & Research PUNE (IISER-PUNE).
  • Advisory Council of Sant Gadge Baba Amravati University, Maharashtra.
  • Governing Body of Ramnarain Ruia Autonomous College, Mumbai. 
  • High Level Advisory Group set up by Ministry of Commerce, Government of India. 

Before joining active politics, he has worked in senior management role in pharmaceutical Research and Development for 18 years, his last role being Vice President (Discovery Research) in Torrent Pharmaceuticals Ltd, Ahmedabad, India. His main expertise is new drug discovery and R&D portfolio management.Three molecules developed by him and his team are in various stages of clinical development. 

Dr Vijay is Ph.D. (Microbiology) from University of Pune, India with 4 years experience as a Post Doctoral Fellow at National Institutes of Health, USA. He has attended executive management program at Indian Institute of Management, Bangalore and leadership development program at London Business School. He also served on the Board of Studies of Indian universities. In 2011, He was also a member of selection committee for the appointment of Vice Chancellor, M. S. University of Baroda, India.

Born in Nagpur, he is a member of Rashtriya Swayamsevak Sangh (RSS) since his childhood.  As a managing trustee and state secretary of non-profit NGO Bharatiya Vichar Manch, Gujarat(BVM) from 2000 to 2013, he was involved in organizing seminars, expert talks, publications, etc on contemporary topics of national and international importance.

He is co-editor of two books entitled “Hindutva in Present Context” (2009) and “The Modi Doctrine: New Paradigms in India’s Foreign Policy” (August 2016 ) which is forwared by Finance Minister Arun Jaitley and released by Minister of External Affairs Minister Sushma Swaraj). 

He has authored peer reviewed scientific papers in international journals and is co-inventor of several global patents and delivered talks in international scientific conferences. He is also a regular columnist on various national and international issues. His columns are published in The Asian Age, Indian Express, The Print, The Quint and vernacular media.

PM Narendra Modi presented with a copy of the book, 'The Modi ...

Dr Jyoti Chauthaiwale (@jvchauthaiwale) | Twitter

Dr Vijay’s wife, Dr Jyoti is Ph D (Biochemistry), is social activist


* Ph.D. (Microbiology) and Post-Doctoral experience in Cell and Molecular Biology.
* 17 years experience in drug discovery and development in metabolic and cardiovascular disorders.

  • London Business School Field Of Study Organizational Behavior Dates attended or expected graduation  –  Activities and Societies: One week program on “Essentials of Leadership” at LBS
  • Indian Institute of Management Bangalore Degree Name Executive Development Program Field Of Study Management Dates attended or expected graduation  – 
  • National Institutes of Health, Bathesda Degree Name Visiting Fellow Field Of Study Molecular and Cell Biology Dates attended or expected graduation  – 


Prerita (@PreritaC) | Twitter

His daughter, Prerita, works fora social media initiative. 

Experience :

  • In-Charge, Foreign Affairs Dept Company Name Bharatiya Janata Party Dates Employed Nov 2014 – Present Employment Duration 5 yrs 10 mos
  • Torrent Pharmaceuticals Ltd Total Duration 10 yrs 8 mos
  • Vice President (Discovery Research)Dates Employed Apr 2008 – Oct 2014 Employment Duration 6 yrs 7 mos Coordinating drug discovery portfolio
  • General Manager (Discovery Research)Dates Employed Mar 2004 – Apr 2008 Employment Duration 4 yrs 2 mos New Drug Discovery


Dr. Vijay has 14 publications


  • TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
  • The Evolving Face of Heart Failure Associated with Elevated Cardio-Metabolic Risk Factors
  • TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats.
  • TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
  • Delayed intervention in experimental stroke with TRC051384 – A small molecule HSP70 inducer
  • TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet.
  • TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes;
  • Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects;
  • TRC4149 a novel advanced glycation end product breaker improves hemodynamic status in diabetic spontaneously hypertensive rats;
  • pRb and p107 regulate E2F activity during lens fiber cell differentiation
  • Expression of alternatively spliced PCTAIRE-1 mRNA in PC12 cells and neonatal rat brain.
  • Sequence of a cDNA encoding the ferritin H-chain from an 11-week-old human fetal brain.
  • Bacteriophage lambda as a cloning vector.
  • TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
We Had Planned To Make Howdy Modi The Biggest Event Of America ...

Vijay, who started out as a molecular biologist has successfully transitioned from being a scientist to developing business for his company. That is evident by his promotion as Vice President of Discovery Research. He is the perfect combination of a scientist and an entrepreneur. As a leader, he not only trusts his subordinates, but also promotes dignity and freedom.

Dr Jyoti Chauthaiwale (@jvchauthaiwale) | Twitter

Follow him on [email protected]

Email Address: [email protected]

You May Also Like